Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

Author： Della Corte Carminia Maria   Fasano Morena   Papaccio Federica   Ciardiello Fortunato   Morgillo Floriana  

Publisher： MDPI

E-ISSN： 2227-9059|2|4|345-358

ISSN： 2227-9059

Source： Biomedicines, Vol.2, Iss.4, 2014-11, pp. : 345-358

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis

By Gaudino Giovanni   Yang Haining   Carbone Michele  

Biomedicines, Vol. 2, Iss. 4, 2014-11 ,pp. : 327-344

MDPI

Access to resources Recommend Favorite

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

By Zhang Yilong   Jain Rajul K.   Zhu Min  

Biomedicines, Vol. 3, Iss. 1, 2015-03 ,pp. : 149-181

MDPI

Access to resources Recommend Favorite

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder

By Lee Young H.   Apolo Andrea B.   Agarwal Piyush K.   Bottaro Donald P.  

Cancers, Vol. 6, Iss. 4, 2014-11 ,pp. : 2313-2329

MDPI

Access to resources Recommend Favorite

HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics

By Mizuno Shinya   Nakamura Toshikazu  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 888-919

MDPI

Access to resources Recommend Favorite

Physiological Signaling and Structure of the HGF Receptor MET

By Baldanzi Gianluca   Graziani Andrea  

Biomedicines, Vol. 3, Iss. 1, 2014-12 ,pp. : 1-31

MDPI

Access to resources Recommend Favorite